Research Article

The Prognostic Value and Potential Mechanism of Tumor-Nutrition-Inflammation Index and Genes in Patients with Advanced Lung Cancer

Table 1

Clinical characteristics of the patients with different AGR and SIRI according to the optimized cut-off value in training dataset.

No. of patients (N = 136)AGR < 1.22 (N = 64)AGR  1.22 (N = 72) valueSIRI < 1.60 (N = 61)SIRI  1.60 (N = 75) value

Gender0.4920.002
 Female40 (29.4%)17 (26.6%)23 (31.9%)26 (42.6%)14 (18.7%)
 Male96 (70.6%)47 (73.4%)49 (68.1%)35 (57.4%)61 (81.3%)
Age0.0890.875
6037 (27.2%)13 (20.3%)24 (33.3%)17 (27.9%)20 (26.7%)
 >6099 (72.8%)51 (79.7%)48 (66.7%)44 (72.1%)55 (73.3%)
History of LC operation0.0050.135
 No102 (75.0%)55 (85.9%)47 (65.3%)42 (68.9%)60 (80.0%)
 Yes34 (25.0%)9 (14.1%)25 (34.7%)19 (31.1%)15 (20.0%)
Differentiation0.1720.078
 Poor36 (26.5%)19 (29.7%)17 (23.6%)12 (19.7%)24 (32.0%)
 Moderately well13 (9.6%)3 (4.7%)10 (13.9%)9 (14.8%)4 (5.3%)
 Unknown87 (64.0%)42 (65.6%)45 (62.5%)40 (65.6%)47 (62.7%)
Pathology0.70.008
 Adenocarcinoma72 (52.9%)35 (54.7%)37 (51.4%)40 (65.6%)32 (42.7%)
 Nonadenocarcinoma64 (47.1%)29 (45.3%)35 (48.6%)21 (34.4%)43 (57.3%)
Mutation0.8220.204
 Positive56 (41.2%)28 (43.8%)28 (38.9%)30 (49.2%)26 (34.7%)
 Negative41 (30.1%)19 (29.7%)22 (30.6%)17 (27.9%)24 (32.0%)
 Unknown39 (28.7%)17 (26.6%)22 (30.6%)14 (23.0%)25 (33.3%)
Bone metastasis0.7630.179
 No114 (83.8%)53 (82.8%)61 (84.7%)54 (88.5%)60 (80.0%)
 Yes22 (16.2%)11 (17.2%)11 (15.3%)7 (11.5%)15 (20.0%)
Brain metastasis0.8690.596
 No114 (83.8%)54 (84.4%)60 (83.3%)50 (82.0%)64 (85.3%)
 Yes22 (16.2%)10 (15.6%)12 (16.7%)11 (18.0%)11 (14.7%)
Adrenal metastasis0.4130.707
 No124 (91.2%)57 (89.1%)67 (93.1%)55 (90.2%)69 (92.0%)
 Yes12 (8.8%)7 (10.9%)5 (6.9%)6 (19.8%)6 (8.0%)
Liver metastasis0.5140.097
 No123 (90.4%)59 (92.2%)64 (88.9%)58 (95.1%)65 (86.7%)
 Yes13 (9.6%)5 (7.8%)8 (11.1%)3 (4.9%)10 (13.3%)
History of smoke0.4790.112
 No70 (51.5%)35 (54.7%)35 (48.6%)36 (59.0%)34 (45.3%)
 Yes66 (48.5%)29 (45.3%)37 (51.4%)25 (41.0%)41 (54.7%)
History of alcohol0.4270.619
 No102 (75.0%)50 (78.1%)52 (72.2%)47 (77.0%)55 (73.3%)
 Yes34 (25.0%)14 (21.9%)20 (27.8%)14 (23.0%)20 (26.7%)
Hypertension0.4440.264
 No89 (65.4%)44 (68.8%)45 (62.5%)43 (70.5%)46 (61.3%)
 Yes47 (34.6%)20 (31.2%)27 (37.5%)18 (29.5%)29 (38.7%)
Diabetes0.6060.881
 No121 (89.0%)56 (87.5%)65 (90.3%)54 (88.5%)67 (89.3%)
 Yes15 (11.0%)8 (12.5%)7 (9.7%)7 (11.5%)8 (10.7%)
BMI0.0080.407
 <18.512 (8.8%)10 (15.6%)2 (2.8%)4 (6.6%)8 (10.7%)
18.5124 (91.2%)54 (84.4%)70 (97.2%)57 (93.4%)67 (89.3%)
CEA0.0180.88
557 (41.9%)20 (31.2%)37 (51.4%)26 (42.6%)31 (41.3%)
 >579 (58.1%)44 (68.8%)35 (48.6%)35 (57.4%)44 (58.7%)
CA1990.0780.602
4395 (69.9%)40 (62.5%)55 (76.4%)44 (72.1%)51 (68.0%)
 >4341 (30.1%)24 (37.5%)17 (23.6%)17 (27.9%)24 (32.0%)
SCC0.1130.361
1.588 (64.7%)37 (57.8%)51 (70.8%)42 (68.9%)46 (61.3%)
 >1.548 (35.3%)27 (42.2%)21 (29.2%)19 (31.0%)29 (38.7%)
AFP0.7340.589
7111 (81.6%)53 (82.8%)58 (80.6%)51 (83.6%)60 (80.0%)
 >725 (18.4%)11 (17.2%)14 (19.4%)10 (16.4%)15 (20.0%)
CRP<0.001<0.001
5.563 (46.3%)14 (21.9%)49 (68.1%)40 (65.6%)23 (30.7%)
 >5.573 (53.7%)50 (78.1%)23 (31.9%)21 (34.4%)52 (69.3%)